Related Experiment Video
Updated: Aug 19, 2025
06:27
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
526
Cellular distribution of IDH mutations in AML during morphologic remission
Radha Ramanan1, Ing Soo Tiong2, Adam Ivey3
1Department of Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia; Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Leukemia Research
|December 2, 2022
Summary
Investigating mutations in acute myeloid leukemia (AML) during remission reveals IDH mutations are restricted to myeloid cells. This myeloid restriction explains why IDH mutations pose a higher relapse risk compared to other mutations.
Area of Science:
- Hematology
- Cancer Genomics
- Molecular Biology
Background:
- Limited data exists on the cellular distribution of persistent mutations in acute myeloid leukemia (AML) during remission.
- These persistent mutations are often considered pre-leukemic clones.
- Understanding mutation distribution is crucial for predicting disease behavior and relapse risk.
